Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies.

Auteurs Mancini SJC, Balabanian K, Corre I, Gavard J, Lazennec G, Le Bousse-Kerdilès MC, Louache F, Maguer-Satta V, Mazure NM, Mechta-Grigoriou F, Peyron JF, Trichet V, Herault O

Frontiers in immunology Jan 2021

The transcriptional repressor Rev-erbα regulates circadian expression of the astrocyte Fabp7 mRNA.

Auteurs Vanderheyden WM, Fang B, Flores CC, Jager J, Gerstner JR

Current research in neurobiology Jan 2021

Prediction of coronary heart disease incidence in a general male population by circulating non-coding small RNA sRNY1-5p in a nested case-control study.

Auteurs Costa VL, Ruidavets JB, Bongard V, Perret B, Repetto E, Stathopoulou MG, Serra F, Benahmed M, Mauduit C, Grandjean V, Ferrières J, Martinez LO, Trabucchi M

Scientific reports Jan 2021

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.

Auteurs Alcaraz LB, Mallavialle A, David T, Derocq D, Delolme F, Dieryckx C, Mollevi C, Boissière-Michot F, Simony-Lafontaine J, Du Manoir S, Huesgen PF, Overall CM, Tartare-Deckert S, Jacot W, Chardès T, Guiu S, Roger P, Reinheckel T, Moali C, Liaudet-Coopman E

Theranostics Jan 2021

Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies.

Auteurs Jaune E, Cavazza E, Ronco C, Grytsai O, Abbe P, Tekaya N, Zerhouni M, Beranger G, Kaminski L, Bost F, Gesson M, Tulic M, Hofman P, Ballotti R, Passeron T, Botton T, Benhida R, Rocchi S

Cell death & disease Jan 2021

Impact of thermogenesis induced by chronic β3-adrenergic receptor agonist treatment on inflammatory and infectious response during bacteremia in mice.

Auteurs Munro P, Rekima S, Loubat A, Duranton C, Pisani DF, Boyer L

PloS one Jan 2021

Arterial Delivery of VEGF-C Stabilizes Atherosclerotic Lesions.

Auteurs Silvestre-Roig C, Lemnitzer P, Gall J, Schwager S, Toska A, Yvan-Charvet L, Detmar M, Soehnlein O

Circulation research Jan 2021

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort.

Auteurs Chiche E, Rahmé R, Bertoli S, Dumas PY, Micol JB, Hicheri Y, Pasquier F, Peterlin P, Chevallier P, Thomas X, Loschi M, Genthon A, Legrand O, Mohty M, Raffoux E, Auberger P, Caulier A, Joris M, Bonmati C, Roth-Guepin G, Lejeune C, Pigneux A, Vey N, Recher C, Ades L, Cluzeau T

Blood advances Jan 2021

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.

Auteurs Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R

Molecular cancer Jan 2021

The Adipose Tissue at the Crosstalk Between EDCs and Cancer Development.

Auteurs Bokobza E, Hinault C, Tiroille V, Clavel S, Bost F, Chevalier N

Frontiers in endocrinology Jan 2021